CVI Try AAC online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00444-07v1
15/3/534    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Cavalli, A.
Right arrow Articles by Buonavoglia, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavalli, A.
Right arrow Articles by Buonavoglia, C.
Clinical and Vaccine Immunology, March 2008, p. 534-539, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00444-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Evaluation of the Antigenic Relationships among Canine Parvovirus Type 2 Variants{triangledown}

Alessandra Cavalli,* Vito Martella, Costantina Desario, Michele Camero, Anna Lucia Bellacicco, Pasquale De Palo, Nicola Decaro, Gabriella Elia, and Canio Buonavoglia

Department of Animal Health and Well-Being, University of Bari, Valenzano, Bari, Italy

Received 7 November 2007/ Returned for modification 5 December 2007/ Accepted 15 December 2007

The antigenic relationships among the original canine parvovirus type 2 (CPV-2) and the variants CPV-2a, -2b, and -2c were evaluated. Cross-antigenic evaluation revealed clear differences among the CPV variants, which were more appreciable by serum neutralization (SN) than by hemagglutination inhibition. Antigenic differences were found mostly between the original CPV-2 and the variants, but they were also observed among the variants CPV-2a, -2b, and -2c. The variant CPV-2c exhibited a unique antigenic pattern, since it was poorly recognized by the sera of animals immunized with CPV-2, CPV-2a, and CPV-2b. However, animals immunized with CPV-2c exhibited higher SN titers to CPV-2b than to the homologous virus CPV-2c. The observed antigenic differences might drive selection of CPV strains by generating differential immune pressure in the canine population, which raises concerns about vaccine efficacy.


* Corresponding author. Mailing address: Dipartimento di Sanità e Benessere Animale, Facoltà di Medicina Veterinaria di Bari, S.p. per Casamassima km 3, 70010 Valenzano, Bari, Italy. Phone: 390804679833. Fax: 390804679843. E-mail: a.cavalli{at}veterinaria.uniba.it

{triangledown} Published ahead of print on 26 December 2007.


Clinical and Vaccine Immunology, March 2008, p. 534-539, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00444-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.